Showing results (201-210 of 398) with videos related to

Sort By:
Pageof 40
Journal of Thrombosis and Haemostasis : JTH|May 19, 2006
Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registryA C Spyropoulos, A G G Turpie, A S Dunn, et al.
Clinical Therapeutics|October 21, 2015
Trends in Prescribing Oral Anticoagulants in Canada, 2008-2014Jeffrey I Weitz, William Semchuk, Alexander G G Turpie, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 28, 2018
Real-world vs. randomized trial outcomes in similar populations of rivaroxaban-treated patients with non-valvular atrial fibrillation in ROCKET AF and XANTUSA John Camm, Pierre Amarenco, Sylvia Haas, et al.
The Science of the Total Environment|December 7, 2018
An environmental flow determination method for integrating multiple-scale ecohydrological and complex ecosystem processes in estuariesLara Van Niekerk, Susan Taljaard, Janine B Adams, et al.
Journal of Thrombosis and Haemostasis : JTH|March 21, 2012
Semuloparin for prevention of venous thromboembolism after major orthopedic surgery: results from three randomized clinical trials, SAVE-HIP1, SAVE-HIP2 and SAVE-KNEEM R Lassen, W Fisher, P Mouret, et al.
Journal of Clinical Epidemiology|December 1, 1993
Measuring quality of life in the frail elderlyG H Guyatt, D J Eagle, B Sackett, et al.
American Journal of Industrial Medicine|January 1, 1989
Concordance of occupational and environmental exposure information elicited from patients with Alzheimer's disease and surrogate respondentsJ P Chong, I Turpie, T Haines, et al.
Journal of Cardiac Failure|July 10, 2013
Heart failure--related mortality and hospitalization in the year following admission to a long-term care facility: the geriatric outcomes and longitudinal decline in heart failure (GOLD-HF) studyAndrea D Foebel, George A Heckman, Kexin Ji, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 14, 2018
Outcomes associated with non-recommended dosing of rivaroxaban: results from the XANTUS studyPierre Amarenco, Sylvia Haas, Susanne Hess, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 28, 2024
Causes of death in patients with atrial fibrillation anticoagulated with rivaroxaban: a pooled analysis of XANTUSPaulus Kirchhof, Sylvia Haas, Pierre Amarenco, et al.
Pageof 40